CRWR.F Stock Overview
Develops, licenses, and supports computer software for the healthcare industry in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Craneware plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£27.80 |
| 52 Week High | UK£30.00 |
| 52 Week Low | UK£23.00 |
| Beta | 0.28 |
| 1 Month Change | 13.42% |
| 3 Month Change | 2.21% |
| 1 Year Change | n/a |
| 3 Year Change | -18.24% |
| 5 Year Change | n/a |
| Change since IPO | 387.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| CRWR.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | -0.002% | -2.4% |
| 1Y | n/a | 2.2% | 23.4% |
Return vs Industry: Insufficient data to determine how CRWR.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how CRWR.F performed against the US Market.
Price Volatility
| CRWR.F volatility | |
|---|---|
| CRWR.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CRWR.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CRWR.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 747 | Keith Neilson | www.thecranewaregroup.com |
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity, which enables healthcare providers to manage, analyze, and plan the deployment of workforce; Trisus Medication Analytic solutions that prioritize, diagnose, and resolve issues in medication systems; and Trisus supplies assistant solutions which supplies charged data.
Craneware plc Fundamentals Summary
| CRWR.F fundamental statistics | |
|---|---|
| Market cap | US$959.93m |
| Earnings (TTM) | US$11.70m |
| Revenue (TTM) | US$189.27m |
82.0x
P/E Ratio5.1x
P/S RatioIs CRWR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRWR.F income statement (TTM) | |
|---|---|
| Revenue | US$189.27m |
| Cost of Revenue | US$27.07m |
| Gross Profit | US$162.20m |
| Other Expenses | US$150.49m |
| Earnings | US$11.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 85.70% |
| Net Profit Margin | 6.18% |
| Debt/Equity Ratio | 10.8% |
How did CRWR.F perform over the long term?
See historical performance and comparisonDividends
1.3%
Current Dividend Yield110%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:28 |
| End of Day Share Price | 2024/12/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Craneware plc is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Chantry | Berenberg |
| Alexander James Short | Berenberg |
| Colin Smith | Capital Access Group |